Boston Scientific Corp. (BSX)
44.58
-1.02
(-2.24%)
USD |
NYSE |
Jun 24, 14:49
Boston Scientific Debt to Equity Ratio : 0.4264 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.4264 |
| December 31, 2025 | 0.494 |
| September 30, 2025 | 0.5149 |
| June 30, 2025 | 0.5365 |
| March 31, 2025 | 0.5271 |
| December 31, 2024 | 0.5158 |
| September 30, 2024 | 0.5437 |
| June 30, 2024 | 0.5368 |
| March 31, 2024 | 0.5521 |
| December 31, 2023 | 0.4923 |
| September 30, 2023 | 0.4924 |
| June 30, 2023 | 0.5187 |
| March 31, 2023 | 0.5246 |
| December 31, 2022 | 0.5282 |
| September 30, 2022 | 0.5065 |
| June 30, 2022 | 0.5408 |
| March 31, 2022 | 0.5786 |
| December 31, 2021 | 0.573 |
| September 30, 2021 | 0.5748 |
| June 30, 2021 | 0.5939 |
| March 31, 2021 | 0.6011 |
| December 31, 2020 | 0.6273 |
| September 30, 2020 | 0.6163 |
| June 30, 2020 | 0.6272 |
| March 31, 2020 | 0.7682 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.7459 |
| September 30, 2019 | 1.155 |
| June 30, 2019 | 1.040 |
| March 31, 2019 | 1.028 |
| December 31, 2018 | 0.8086 |
| September 30, 2018 | 0.7994 |
| June 30, 2018 | 0.8385 |
| March 31, 2018 | 0.8201 |
| December 31, 2017 | 0.8009 |
| September 30, 2017 | 0.7488 |
| June 30, 2017 | 0.8065 |
| March 31, 2017 | 0.7818 |
| December 31, 2016 | 0.8145 |
| September 30, 2016 | 0.8369 |
| June 30, 2016 | 0.8725 |
| March 31, 2016 | 0.8792 |
| December 31, 2015 | 0.8983 |
| September 30, 2015 | 0.914 |
| June 30, 2015 | 0.7769 |
| March 31, 2015 | 0.6565 |
| December 31, 2014 | 0.6573 |
| September 30, 2014 | 0.6345 |
| June 30, 2014 | 0.6502 |
| March 31, 2014 | 0.6503 |
| December 31, 2013 | 0.6484 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.654 |
| Insulet Corp. | 0.7279 |
| Penumbra, Inc. | 0.1467 |
| Intuitive Surgical, Inc. | 0.00 |
| Stryker Corp. | 0.663 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 44.35B |
| Total Liabilities (Quarterly) | 18.25B |
| Shareholders Equity (Quarterly) | 25.86B |
| Current Ratio | 1.900 |
| Net Debt Paydown Yield | 0.04% |